Cqenc Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-06-2024
- Paid Up Capital ₹ 0.70 M
as on 18-06-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 34.12%
(FY 2023)
- Profit -67.57%
(FY 2023)
- Ebitda 290.02%
(FY 2023)
- Net Worth 267.74%
(FY 2023)
- Total Assets 7.12%
(FY 2023)
About Cqenc Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M, as per Ministry of Corporate Affairs (MCA) records.
Ruchi Agarwal and Shubham Sharma serve as directors at the Company.
- CIN/LLPIN
U74999DL2018PTC329247
- Company No.
329247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gandhi Nagar, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cqenc Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ruchi Agarwal | Additional Director | 22-Jan-2024 | Current |
Shubham Sharma  | Director | 07-Feb-2018 | Current |
Financial Performance and Corporate Structure Insights of Cqenc Pharma.
Cqenc Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.12% increase. The company also saw a substantial fall in profitability, with a 67.57% decrease in profit. The company's net worth Soared by an impressive increase of 267.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cqenc Pharma?
In 2023, Cqenc Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cqenc Pharma?
Unlock and access historical data on people associated with Cqenc Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cqenc Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cqenc Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
